HomeLSL • CVE
add
LSL Pharma Group Inc
Previous close
$0.36
Day range
$0.35 - $0.36
Year range
$0.29 - $0.53
Market cap
41.84M CAD
Avg Volume
73.89K
P/E ratio
14.58
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 7.58M | 88.97% |
Operating expense | 1.94M | 74.82% |
Net income | -1.18M | -205.70% |
Net profit margin | -15.58 | -61.79% |
Earnings per share | — | — |
EBITDA | 1.10M | 150.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 60.19M | 58.57% |
Total liabilities | 34.81M | 97.92% |
Total equity | 25.38M | — |
Shares outstanding | 115.53M | — |
Price to book | 1.61 | — |
Return on assets | 1.61% | — |
Return on capital | 1.98% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.18M | -205.70% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2010
Website
Employees
185
